NVCR (NVCR) Stock Price & Analysis
NVCR (NVCR) rose 1.70% to USD 17.94 as of September 8, 2026 at 06:58 UTC, according to Nexqual real-time market data.
NVCR last closed at USD 17.94; the session ranged USD 17.47–18.01 on volume of 732,170 shares. Market capitalization is —, with a 52-week range of USD 9.82–21.45 (NMS). Source: Nexqual, September 8, 2026 at 06:58 UTC.
Key Statistics (as of September 8, 2026 at 06:58 UTC)
| Price | USD 17.94 |
|---|---|
| Change | ▲ 1.70% (up) |
| Previous Close | USD 17.94 |
| Open | USD 17.94 |
| Day Range | USD 17.47 – 18.01 |
| 52-Week Range | USD 9.82 – 21.45 |
| Volume | 732,170 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (NVCR)
Nexqual's technical model rates NVCR "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:58 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 55.25 (neutral) |
| vs SMA50 | Above (USD 16.8) |
| MACD | 0.31 (positive) |
From NVCR's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GH | Guardant Health, Inc. | USD 161.41 | ▼ 1.01% |
| RGEN | Repligen Corporation | USD 167.6 | ▼ 3.09% |
| QDEL | QuidelOrtho Corporation | USD 13.97 | ▲ 0.14% |
| DXCM | DexCom, Inc. | USD 87.9 | ▼ 2% |
| FLGT | Fulgent Genetics, Inc. | USD 19.73 | ▼ 1.55% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:58 UTC. This page is informational and not investment advice.